PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DR. Reddy's Laboratories Limited

USPTO PatentsView assignee record - 99 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dr. ranks #3,678 of 49,997 tracked US assignees by granted-patent volume, with 99 patents across 20 technology areas.

#3,678
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.7/100)
17.0
avg claims per patent
-64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3678 · Foreign Corporation #3,678 · 99 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 99 grants
  • TOP-DECILE #3,678/49,997
  • PHOTO-FINISH BorgWarner Ludwigsburg
  • CPC-FOCUS A61P · 20 areas
  • INNOV-PAR 43.7/100
  • CLAIMS-RICH 17.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -64% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: BorgWarner Ludwigsburg GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dr.’s 43.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Dr.

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Dr.'s Innovation Score is 43.7/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Dr.?

Each dot is one of Dr.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dr.’s own 17.0 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dr. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 98.999.099.09999.099.099.1 101520253035 Granted patents (volume) Avg claims / patent BorgWarner Ludwigsburg GmbH - 99, 11.92Borgwarner Ludwig…Christie Digital Systems USA, Inc. - 99, 16.88Christie Digital…Cooledge Lighting Inc. - 99, 30.92Cooledge LightingCorteva Agriscience LLC - 99, 14.64Corteva Agriscien…Dura Operating, LLC - 99, 18.31Dura OperatingESS Tech, Inc. - 99, 14.59ESS TechExel Industries - 99, 13.33Exel IndustriesFidelity Information Services, LLC - 99, 18.22Fidelity Informat…DR. Reddy's Laboratories Limited - 99, 17.01DR Reddy's Labora…
Dr. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dr.'s grants concentrate

DR. Reddy's Laboratories Limited is a focused PatentsView assignee: 20 CPC subclasses with 70.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (18 grants) versus a trough of 1 in 2023. By volume, Dr. sits between BorgWarner Ludwigsburg GmbH and Fidelity Information Services, LLC.

Dr.'s three-year grant acceleration

From 2019–2021 to 2022–2024, DR. Reddy's Laboratories Limited moved from 26 to 7 grants (0.27x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at DR's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows DR. holds 99 patents at rank #3,678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near DR

By rank, the assignees closest to #3,678 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in DR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for DR, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), DR ranks #242 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

ConsumerInfo.com, Inc. 44 NCS Multistage Inc. 44 BOS GMBH & Co. KG 44 Technoprobe S.P.A. 44

Similar claim depth

Nearest assignees by average claims per patent (17.0 here).

Wangs Alliance Corporation 17.0 avg LDR Medical 17.0 avg EGALAX_EMPIA Technology Inc. 17.0 avg Cedars Sinai Medical Center 17.0 avg

Dr.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
DR. Reddy's Laboratories Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 14 14.1%
2016 18 18.2%
2017 16 16.2%
2018 17 17.2%
2019 7 7.1%
2020 10 10.1%
2021 9 9.1%
2022 4 4.0%
2023 1 1.0%
2024 2 2.0%
2025partial year 1 1.0%

Which technologies does DR. Reddy's Laboratories Limited patent most?

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

DR. Reddy's Laboratories Limited's patent record in context - here's where to go next.

  • DR. Reddy's Laboratories Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #3,678 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare DR. Reddy's Laboratories Limited against BorgWarner Ludwigsburg GmbH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.